TM6SF2 E167K Variant Overexpression Promotes Expression of Inflammatory Cytokines in the HCC Cell Line HEPA 1-6
Published: 8 February 2019
Journal of Clinical and Translational Hepatology , Volume 7, pp 27-31; doi:10.14218/JCTH.2018.00055
Abstract: Background and Aims: Accumulated evidence has shown that chronic liver inflammation is one of the main risks of hepatocellular carcinoma (HCC), and E167K variant of the transmembrane 6 superfamily member 2 (TM6SF2) plays an important role in the progression of chronic liver diseases and HCC. The aim of this study was to explore effects of the TM6SF2 E167K variant on expression of the inflammatory cytokines TNF-α, IL-2, IL-6 and IL-8 in the HCC cell line HEPA 1-6.
Keywords: Hepatocellular carcinoma / inflammatory / Tm6sf2 / E167k Variant
Click here to see the statistics on "Journal of Clinical and Translational Hepatology" .